Select country set
language
Menu Shopping cart 0,00 Search
Manufactured by BioVendor

SARS-CoV-2 Spike Glycoprotein California/CAL.20C Mutation B.1.429, HEK293

  • Regulatory status:RUO
  • Type:Recombinant protein
  • Source:HEK293
  • Other names:Severe acute respiratory syndrome coronavirus 2 spike glycoprotein, 2019 novel coronavirus Spike protein, COVID-19
  • Species:SARS-CoV-2
Please select your region to see available products and prices.
Cat. No. Size Price


New RB978613100 0.1 mg
New RB9786131000 0.1 mg
PubMed Product Details
Technical Data

Type

Recombinant protein

Description

SARS-CoV-2 Spike glycoprotein, Californian Variant B.1.429. Active trimeric form. UniProt acc. no. P0DTC2. Full-length sequence aa 1 –1273. Mutations: S13I, W152C, L452R, D1183Y. Further mutations: furin cleavage site RRAR modified to GSAG, K986P, V987P. C-terminal tag.

Source

HEK293

Purity

98% as determined by SDS-PAGE

Formulation

Liquid in buffer 20 mM Hepes pH 7.5; 150 mM NaCl, 0.001% LMNG

Reconstitution

Defrost at ambient temperature.

Applications

Western blotting, ELISA, COVID-19, ligand binding assays

Shipping

On ice. Upon receipt, store the product at the temperature recommended below.

Storage/Expiration

Store protein at –80°C. Protein remains stable until the expiry date when stored at –80°C. Avoid repeated freezing/thawing cycles.

Note

This product is intended for research use only.

Summary

Research topic

COVID-19

Related Products